WO1999062945A3 - Peptide antigens for detection of hiv, hcv and other microbial infections - Google Patents
Peptide antigens for detection of hiv, hcv and other microbial infections Download PDFInfo
- Publication number
- WO1999062945A3 WO1999062945A3 PCT/US1999/012446 US9912446W WO9962945A3 WO 1999062945 A3 WO1999062945 A3 WO 1999062945A3 US 9912446 W US9912446 W US 9912446W WO 9962945 A3 WO9962945 A3 WO 9962945A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- peptide
- naturally occurring
- disease
- advantageous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU45463/99A AU4546399A (en) | 1998-06-05 | 1999-06-04 | Universal peptides |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8822998P | 1998-06-05 | 1998-06-05 | |
US60/088,229 | 1998-06-05 | ||
US9870598P | 1998-09-01 | 1998-09-01 | |
US60/098,705 | 1998-09-01 | ||
US10042298P | 1998-09-15 | 1998-09-15 | |
US60/100,422 | 1998-09-15 | ||
PCT/US1999/001726 WO1999038887A1 (en) | 1998-01-28 | 1999-01-28 | Divergent hiv-1 peptides |
USPCT/US99/01726 | 1999-01-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999062945A2 WO1999062945A2 (en) | 1999-12-09 |
WO1999062945A9 WO1999062945A9 (en) | 2000-05-04 |
WO1999062945A3 true WO1999062945A3 (en) | 2000-06-29 |
Family
ID=27492207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/012446 WO1999062945A2 (en) | 1998-06-05 | 1999-06-04 | Peptide antigens for detection of hiv, hcv and other microbial infections |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1999062945A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100564C (en) * | 2001-08-29 | 2003-02-05 | 周根发 | Medicine for treating HIV infection, its composition and its use |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993006488A1 (en) * | 1991-09-16 | 1993-04-01 | Genelabs Technologies, Inc. | Peptide based hepatitis c virus immunoassays |
EP0591914A2 (en) * | 1992-10-06 | 1994-04-13 | BEHRINGWERKE Aktiengesellschaft | Retrovirus of the HIV-group and its application |
DE4405810A1 (en) * | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
WO1996012809A2 (en) * | 1994-10-20 | 1996-05-02 | Institut Pasteur | Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
WO1996027013A1 (en) * | 1995-02-27 | 1996-09-06 | Institut National De La Sante Et De La Recherche Medicale-Inserm | Group o hiv-1, fragments of such viruses, and uses thereof |
WO1998045318A1 (en) * | 1997-04-07 | 1998-10-15 | Syva Company | Activated peptides and conjugates |
WO1999004011A2 (en) * | 1997-07-18 | 1999-01-28 | Innogenetics N.V. | Hiv-1 group o antigens and uses thereof |
WO1999045395A1 (en) * | 1998-03-04 | 1999-09-10 | Universal Healthwatch, Inc. | Rapid confirmatory test for microbial infections |
-
1999
- 1999-06-04 WO PCT/US1999/012446 patent/WO1999062945A2/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993006488A1 (en) * | 1991-09-16 | 1993-04-01 | Genelabs Technologies, Inc. | Peptide based hepatitis c virus immunoassays |
EP0591914A2 (en) * | 1992-10-06 | 1994-04-13 | BEHRINGWERKE Aktiengesellschaft | Retrovirus of the HIV-group and its application |
DE4405810A1 (en) * | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
WO1996012809A2 (en) * | 1994-10-20 | 1996-05-02 | Institut Pasteur | Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
WO1996027013A1 (en) * | 1995-02-27 | 1996-09-06 | Institut National De La Sante Et De La Recherche Medicale-Inserm | Group o hiv-1, fragments of such viruses, and uses thereof |
WO1998045318A1 (en) * | 1997-04-07 | 1998-10-15 | Syva Company | Activated peptides and conjugates |
WO1999004011A2 (en) * | 1997-07-18 | 1999-01-28 | Innogenetics N.V. | Hiv-1 group o antigens and uses thereof |
WO1999045395A1 (en) * | 1998-03-04 | 1999-09-10 | Universal Healthwatch, Inc. | Rapid confirmatory test for microbial infections |
Non-Patent Citations (1)
Title |
---|
SCHABLE ET AL: "Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections", SYNTHESIS, vol. 344, no. 344, 12 November 1994 (1994-11-12), pages 1333/1334, XP002098165 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999062945A2 (en) | 1999-12-09 |
WO1999062945A9 (en) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2752329B2 (en) | Method for producing envelope antigen of virus of lymphadenopathy and acquired immunodeficiency syndrome | |
EP0328403A3 (en) | Synthetic peptides related to the hiv-gp120-env-protein, and their use | |
KR950032278A (en) | Peptides Derived from Retroviruses of the Human Immunodeficiency Virus Group and Uses thereof | |
RU2006105498A (en) | POLYEPEPTIDES FOR THE INDUCTION OF A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS | |
CA2096159A1 (en) | Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates | |
IL152507A0 (en) | Methods and compositions for impairing multiplication of hiv-1 | |
CA2380833A1 (en) | Proteins derived from white spot syndrome virus and uses thereof | |
CA2391356A1 (en) | Peptides designed for the diagnosis and treatment of rheumatoid arthritis | |
US4755380A (en) | Peptide from amyloid A and antiserum therefor | |
SE9900812D0 (en) | Immune direction therapy | |
WO1999062945A3 (en) | Peptide antigens for detection of hiv, hcv and other microbial infections | |
JP2003522185A5 (en) | ||
ATE357526T1 (en) | MODIFIED HCV PEPTIDE VACCINES | |
IL156799A (en) | Peptides having affinity for the gp120 viral protein and use thereof | |
WO2003022879B1 (en) | Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them | |
WO2001029177A3 (en) | Hiv-1 subtype d peptides | |
RU2184742C2 (en) | Synthetic peptides using in biological tests for detection infections caused by viruses hiv-1 of group 0 | |
CORDIALI et al. | Convergent evolution in the homology between HIV gp160 and HLA class II molecules | |
AU6393990A (en) | Hiv related peptides | |
WO1998037089A3 (en) | Matrix derived anti-hiv peptides and transdominant proteins | |
WO1996027012A1 (en) | Specific hiv-1 group o antigens | |
WO2000001719A3 (en) | Peptides from varicella-zoster and other viruses for hiv-2 diagnosis and therapy | |
Crescenzi et al. | Synthetic peptides in diagnosis of plum pox potyvirus | |
MXPA04007646A (en) | Immunogenic formulations of variable peptidic epitopes and process for preparation thereof. | |
US6555091B1 (en) | Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/6-6/6, DRAWINGS, REPLACED BY NEW PAGES 1/7-7/7; PAGES 60-75, SEQUENCE LISTING, RENUMBERED AS PAGES 1-16; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |